CS logo
small CS logo
Resocentro

Lima, Peru
Medical diagnostic imaging center in Peru
Av. Petit Thouars 4427, Miraflores 15046

About Resocentro


"Centro de diagnóstico por imágenes, realizamos estudios de resonancia magnética abierta, de alto campo y de 3 Teslas. Además ofrecemos tomografía espiral multicorte y Fibroscan. 25 años de experiencia."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Total Rows: 1

Clinical Trials at Resocentro


During the past decade, Resocentro conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)
2014-02-24
2020-06-27
Completed
707
A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
2014-09-30
2018-04-19
Completed
394

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 2Pfizer: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Resocentro


According to Clinical.Site data, the most researched conditions in "Resocentro" are "Follicular Lymphoma" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Resocentro" in a lesser frequency.

Clinical Trials Intervention Types at Resocentro


Most popular intervention types in "Resocentro" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Herceptin®" (1 trials), "MabThera®" (1 trials), "PF-05280014" (1 trials), "PF-05280586" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Resocentro


The vast majority of trials in "Resocentro" are 1 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Resocentro


Currently, there are NaN active trials in "Resocentro". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Resocentro, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Resocentro, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 2Completed: 2